Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Í viðhengi er tilkynning um viðskipti stjórnenda og tengdra aðila sem send var inn til fjármálaeftirlits Lúxemborgar, Luxembourg Commission de Surveillance du Secteur Financier (CSSF), varðandi kaup...
-
Not to be released, published, distributed or circulated in the United States or any other jurisdiction in which it would be unlawful to do so. This press release is for information purposes only and...
-
Total Revenues in the first quarter of 2025 reached $132.8 million, compared to $36.9 million in the same period last year, representing a 260% increase Product Revenues in the first in the first...
-
Heildartekjur á fyrsta fjórðungi ársins voru 132,8 milljónir dollara, samanborið við 36,9 milljónir á sama fjórðungi í fyrra, sem er 260% aukning Sölutekjur á fyrsta fjórðungi ársins voru 109,9...
-
Total Revenues in the first quarter of 2025 reached $132.8 million, compared to $36.9 million in the same period last year, representing a 260% increaseProduct Revenues in the first in the first...
-
REYKJAVIK, Iceland, May 07, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO) (the “Company”) a global biotech company specializing in the development and manufacture of biosimilar medicines for...
-
Alvotech (NASDAQ: ALVO) (the “Company”) a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today issued a statement on the...
-
Alvotech (NASDAQ: ALVO) áætlar að mögulegir tollar á innflutning lyfja til Bandaríkjanna hefðu hverfandi áhrif á tekjur félagsins af sölu lyfja á árinu. Vöruinnflutningur frá Íslandi fellur undir...
-
The U.S. FDA has approved SELARSDI™ (ustekinumab-aekn) as interchangeable with the reference biologic Stelara® (ustekinumab) in all presentations matching the reference product, effective as of April...
-
Matvæla- og lyfjastofnun Bandaríkjanna (FDA) hefur heimilað sölu Selarsdi með útskiptileika við frumlyfið við Stelara, fyrir öll lyfjaform og ábendingar frumlyfsins, frá og með 30. apríl sl. Selarsdi...